Document is current
Any future updates will be listed below
-
Authors
Bouras, Emmanouil
Karhunen, Ville
Gill, Dipender
Huang, Jian
Haycock, Philip C.
Gunter, Marc J.
Johansson, Mattias
Brennan, Paul
Key, Tim
Lewis, Sarah J.
Martin, Richard M.
Murphy, Neil
Platz, Elizabeth A.
Travis, Ruth
Yarmolinsky, James
Zuber, Verena
Martin, Paul
Katsoulis, Michail
Freisling, Heinz
Nøst, Therese Haugdahl
Schulze, Matthias B.
Dossus, Laure
Hung, Rayjean J.
Amos, Christopher I.
Ahola-Olli, Ari
Palaniswamy, Saranya
Männikkö, Minna
Auvinen, Juha
Herzig, Karl-Heinz
Keinänen-Kiukaanniemi, Sirkka
Lehtimäki, Terho
Salomaa, Veikko
Raitakari, Olli
Salmi, Marko
Jalkanen, Sirpa
,
CRUK,
,
CAPS,
PEGASUS,
Jarvelin, Marjo-Riitta
Dehghan, Abbas
Tsilidis, Konstantinos K.
-
Funding
Funding for this research was provided by:
cancer research uk (C18281/A29019)
- License Information
-
More Information
Article History
Received: 19 July 2021
Accepted: 18 November 2021
First Online: 11 January 2022
Declarations
:
: Not applicable.
: We confirm that this manuscript has been approved by all authors to be published in the BMC Medicine.
: I have read the journal’s policy and the authors of this manuscript have the following competing interests: DG is employed part-time by Novo Nordisk. VS has received honoraria from Novo Nordisk and Sanofi for consulting. He also has ongoing research collaboration with Bayer Ltd. (All unrelated to the present study). These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors have no competing interests to declare.
